sub:provenance {
beldoc: dce:description "Approximately 61,000 statements." ;
dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
dce:title "BEL Framework Large Corpus Document" ;
pav:authoredBy sub:_6 ;
pav:version "20131211" .
sub:_5 prov:value "In hyperplastic lung tissues and in tumors induced at early times after BRafVE expression, a high percentage of cells stain positive for Ki67 (Fig. 4E,F), phospho-histone H3, and BrdU incorporation. However, in tumors observed at later times, the percentage of Ki67-positive cells is dramatically decreased even though the BRafVE–MEK–ERK signaling pathway remains active in these cells (Figs. 3A,B, 4G)." ;
prov:wasQuotedFrom pubmed:17299132 .
sub:_6 rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:17299132 ;
prov:wasDerivedFrom beldoc: ,
sub:_5 .
}